Cited by

• Vaccine effectiveness to protect against moderate or severe disease in COVID cases: A prospective cohort study.

  Joshi RK, Muralidharan CG, Ahuja A, Mukherjee R, Chaurasia S, Manjaly L, Divyanshi, Sahoo AK, Gosavi J, Thomas A. Joshi RK, et al. Med J Armed Forces India. 2022 Apr 4;79(Suppl 1):S102-11. doi: 10.1016/j.mjafi.2022.02.001. Online ahead of print. Med J Armed Forces India. 2022. PMID: 35400799 Free PMC article.
• The characteristics of and responses to the two COVID-19 outbreak waves in Hebei Province of China, January 2020 to February 2021.

  Cheng X, Li Y, Zhang Y, Lu J. Cheng X, et al. Epidemiol Infect. 2021 Sep 17;149:e212. doi: 10.1017/S0950268821002089. Epidemiol Infect. 2021. PMID: 35285437 Free PMC article.
• How to organise travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore.

  Lai D, Cai Y, Chan TH, Gan D, Hurson AN, Zhang YD. Lai D, et al. BMJ Glob Health. 2022 Feb;7(2):e006975. doi: 10.1136/bmjgh-2021-006975. BMJ Glob Health. 2022. PMID: 35228258 Free PMC article.
• The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey.

  Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, Fox C, Kapteyn A. Szilagyi PG, et al. Prev Med. 2021 Dec;153:106727. doi: 10.1016/j.ypmed.2021.106727. Epub 2021 Jul 16. Prev Med. 2021. PMID: 34280405 Free PMC article.
• Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?

  da Silva KN, Gobatto ALN, Costa-Ferro ZSM, Cavalcante BRR, Caria ACI, de Aragão França LS, Nonaka CKV, de Macêdo Lima F, Lopes-Pacheco M, Rocco PRM, de Freitas Souza BS. da Silva KN, et al. Stem Cell Res Ther. 2021 Jul 27;12(1):425. doi: 10.1186/s13287-021-02502-7. Stem Cell Res Ther. 2021. PMID: 34315546 Free PMC article. Review.